loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2012_238___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    SINTENOVO, S.A. DE C.V.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SINTENOVO S.A. DE C.V. Barcelona ES (1)

    filter

    01 Olmesartan medoxomil (1)

    filter

    01 Mexico (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    SINTENOVO S.A. DE C.V. Barcelona ES

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Mexico
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Olmesartan medoxomil

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2012-238 - Rev 01
    Withdrawn by Holder
    Chemical
    2015-04-22
    2018-07-27
    2600
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2012-238 - Rev 01 of Sintenovo S.a. De C.v. Barcelona Es

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2012-238 - Rev 01 of Sintenovo S.a. De C.v. Barcelona Es 1

    20

    Sintenovo S.a. De C.v. Barcelona Es, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Olmesartan medoxomil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2012-238 - Rev 01

    This Chemical Type CEP, issued on April 22, 2015, remains in force until July 27, 2018, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2600 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY